IQVIA (NYSE:IQV – Get Free Report) had its price target increased by investment analysts at JPMorgan Chase & Co. from $225.00 to $285.00 in a research note issued on Wednesday,Benzinga reports. BMO Capital Markets raised their target price on IQVIA from $210.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday. Thirteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Get IQVIA alerts:Check Out Our Latest Stock Report on IQVIAIQVIA Stock Up 1.4%IQVIA stock traded up $3.49 during midday trading on Wednesday, hitting $246.43. JPMorgan Chase & Co. now owns 3,799,600 shares of the medical research company’s stock valued at $856,468,000 after buying an additional 528,753 shares during the period.